GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syncom Formulation (India) Ltd (NSE:SYNCOMF) » Definitions » Piotroski F-Score

Syncom Formulation (India) (NSE:SYNCOMF) Piotroski F-Score : 6 (As of May. 24, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Syncom Formulation (India) Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Syncom Formulation (India) has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Syncom Formulation (India)'s Piotroski F-Score or its related term are showing as below:

NSE:SYNCOMF' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 7
Current: 6

During the past 13 years, the highest Piotroski F-Score of Syncom Formulation (India) was 7. The lowest was 4. And the median was 6.


Syncom Formulation (India) Piotroski F-Score Historical Data

The historical data trend for Syncom Formulation (India)'s Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncom Formulation (India) Piotroski F-Score Chart

Syncom Formulation (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 6.00 4.00 5.00 6.00

Syncom Formulation (India) Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 - - - 6.00

Competitive Comparison of Syncom Formulation (India)'s Piotroski F-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Syncom Formulation (India)'s Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syncom Formulation (India)'s Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syncom Formulation (India)'s Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Syncom Formulation (India)'s Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Net Income was ₹253 Mil.
Cash Flow from Operations was ₹-60 Mil.
Revenue was ₹2,634 Mil.
Gross Profit was ₹1,065 Mil.
Average Total Assets from the begining of this year (Mar23)
to the end of this year (Mar24) was (3778.305 + 4046.639) / 2 = ₹3912.472 Mil.
Total Assets at the begining of this year (Mar23) was ₹3,778 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0 Mil.
Total Current Assets was ₹2,748 Mil.
Total Current Liabilities was ₹1,065 Mil.
Net Income was ₹201 Mil.

Revenue was ₹2,243 Mil.
Gross Profit was ₹826 Mil.
Average Total Assets from the begining of last year (Mar22)
to the end of last year (Mar23) was (3082.383 + 3778.305) / 2 = ₹3430.344 Mil.
Total Assets at the begining of last year (Mar22) was ₹3,082 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0 Mil.
Total Current Assets was ₹1,817 Mil.
Total Current Liabilities was ₹1,132 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Syncom Formulation (India)'s current Net Income (TTM) was 253. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Syncom Formulation (India)'s current Cash Flow from Operations (TTM) was -60. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar23)
=253.142/3778.305
=0.06699883

ROA (Last Year)=Net Income/Total Assets (Mar22)
=200.707/3082.383
=0.06511423

Syncom Formulation (India)'s return on assets of this year was 0.06699883. Syncom Formulation (India)'s return on assets of last year was 0.06511423. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Syncom Formulation (India)'s current Net Income (TTM) was 253. Syncom Formulation (India)'s current Cash Flow from Operations (TTM) was -60. ==> -60 <= 253 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=0/3912.472
=0

Gearing (Last Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=0/3430.344
=0

Syncom Formulation (India)'s gearing of this year was 0. Syncom Formulation (India)'s gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar24)=Total Current Assets/Total Current Liabilities
=2747.825/1065.246
=2.57952154

Current Ratio (Last Year: Mar23)=Total Current Assets/Total Current Liabilities
=1816.873/1131.596
=1.6055845

Syncom Formulation (India)'s current ratio of this year was 2.57952154. Syncom Formulation (India)'s current ratio of last year was 1.6055845. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Syncom Formulation (India)'s number of shares in issue this year was 744.535. Syncom Formulation (India)'s number of shares in issue last year was 836.279. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1065.067/2633.871
=0.40437326

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=825.583/2242.542
=0.36814606

Syncom Formulation (India)'s gross margin of this year was 0.40437326. Syncom Formulation (India)'s gross margin of last year was 0.36814606. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar23)
=2633.871/3778.305
=0.69710386

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar22)
=2242.542/3082.383
=0.72753516

Syncom Formulation (India)'s asset turnover of this year was 0.69710386. Syncom Formulation (India)'s asset turnover of last year was 0.72753516. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+0+1+0+1+1+1+1+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Syncom Formulation (India) has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Syncom Formulation (India)  (NSE:SYNCOMF) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Syncom Formulation (India) Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Syncom Formulation (India)'s Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Syncom Formulation (India) (NSE:SYNCOMF) Business Description

Traded in Other Exchanges
Address
207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018
Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

Syncom Formulation (India) (NSE:SYNCOMF) Headlines

No Headlines